Millendo Therapeutics (Millendo Therapeutics) Total Payout Ratio : -0.00 (As of May. 05, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Millendo Therapeutics Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Millendo Therapeutics's current Total Payout Ratio is -0.00.

Millendo Therapeutics Total Payout Ratio Historical Data

The historical data trend for Millendo Therapeutics's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Millendo Therapeutics Total Payout Ratio Chart

Millendo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Total Payout Ratio

Get a 7-Day Free Trial

0.66

1.43

0.60

0.15

Millendo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Payout Ratio	Get a 7-Day Free Trial															0.46	0.01	-	-0.03	-

Competitive Comparison of Millendo Therapeutics's Total Payout Ratio

For the Biotechnology subindustry, Millendo Therapeutics's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Millendo Therapeutics's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Millendo Therapeutics's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Millendo Therapeutics's Total Payout Ratio falls into.

Millendo Therapeutics Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Millendo Therapeutics's Total Payout Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	5.453	+	0)	/	-36.406
	=	0.15

Millendo Therapeutics's Total Payout Ratio for the quarter that ended in Mar. 2021 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-8.389
	=	0.00

Millendo Therapeutics Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Millendo Therapeutics's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Millendo Therapeutics (Millendo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Millendo Therapeutics Inc (NAS:MLND) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

110 Miller Avenue, Suite 100, Ann Arbor, MI, USA, 48104

Website

https://www.millendo.com

Millendo Therapeutics Inc is a biopharmaceutical company.

Executives

Mary Lynne Hedley	director	C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Howe John P Md	director	C/O BB&T, P O BOX 1250, WINSTON SALEM NC 27102-1250
Carol Giltner Gallagher	director	C/O ATARA BIOTHERAPEUTICS, INC., 3260 BAYSHORE BOULEVARD, BRISBANE CA 94005
Habib J Dable	director	C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139
Carole Nuechterlein	director	C/O AVEXIS, INC., 2275 HALF DAY ROAD, SUITE 160, BANNOCKBURN IL 60015
Geoffrey Nichol	director	MEDAREX, 707 STATE ROAD, PRINCETON NJ 08540
James M. Hindman	director	2525 DUPONT DRIVE, IRVINE CA 92612
Christophe Arbet-engels	officer: Chief Medical Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Ryan Zeidan	officer: Chief Development Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Julia C. Owens	director, officer: President and CEO	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Tamara L Joseph	officer: General Counsel and Secretary	32 GARRISON STREET, APT 50-103, BOSTON MA 02116
Arcudi Iii Louis J	officer: Chief Financial Officer	C/O IDERA PHARMACEUTICALS 167 SYDNEY ST, CAMBRIDGE MA 02139
Randall W Whitcomb	director	10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
Jeffery M. Brinza	officer: Sec., CAO and General Counsel	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Pharis Mohideen	officer: Chief Medical Officer	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451